Drreddys Laboratories | Ativos



Assets Alterar Data
ANI Pharmaceuticals USD 1.34B 50.57M 2025-06
Aurora Cannabis CAD 837.84M 28.68M 2025-06
Bayer EUR 105.24B 3.95B 2025-06
Canopy Growth CAD 904.67M 259.55M 2025-06
Cipla INR 373.87B 27.32B 2025-03
Corcept Therapeutics USD 801.72M 44.73M 2025-06
Drreddys Laboratories INR 519.54B 38.48B 2025-06
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Hikma Pharmaceutical USD 5.13B 286M 2024-12
Lonza CHF 19.73B 1.85B 2024-12
Novartis USD 104.4B 4.45B 2025-06
Pacira USD 1.54B 49.41M 2025-06
Prestige Brands USD 3.43B 29.41M 2025-06
Richter Gedeon HUF 1.6T 116.26B 2024-12
Sun Pharmaceuticals INR 921.01B 39.85B 2025-03
Supernus Pharmaceuticals USD 1.38B 35.11M 2025-06
Teva Pharmaceutical Industries USD 40.13B 1.72B 2025-06


Drreddys Laboratories Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Sep 2025.